| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Animal house: University risk environments and the regulation of students’ alcohol use
|
Wilkinson, Blair
|
|
2017
|
47 |
C |
p. 18-25
8 p.
|
artikel
|
| 2 |
Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada
|
Capler, Rielle
|
|
2017
|
47 |
C |
p. 1-8
8 p.
|
artikel
|
| 3 |
Call for Papers Themed Collection Parents and substance use; management of risky parenthood
|
|
|
2017
|
47 |
C |
p. 245-
1 p.
|
artikel
|
| 4 |
Call for Paper: Themed Collection: Sexualised drug use: LGBT communities and beyond
|
|
|
2017
|
47 |
C |
p. 244-
1 p.
|
artikel
|
| 5 |
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study
|
Midgard, Håvard
|
|
2017
|
47 |
C |
p. 230-238
9 p.
|
artikel
|
| 6 |
Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California
|
Horyniak, Danielle
|
|
2017
|
47 |
C |
p. 9-17
9 p.
|
artikel
|
| 7 |
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
|
Read, Phillip
|
|
2017
|
47 |
C |
p. 209-215
7 p.
|
artikel
|
| 8 |
DOT-C: A cluster randomised feasibility trial evaluating directly observed anti-HCV therapy in a population receiving opioid substitute therapy from community pharmacy
|
Radley, Andrew
|
|
2017
|
47 |
C |
p. 126-136
11 p.
|
artikel
|
| 9 |
Effectiveness and cost-effectiveness of nationwide campaigns for awareness and case finding of hepatitis C targeted at people who inject drugs and the general population in the Netherlands
|
Helsper, Charles W.
|
|
2017
|
47 |
C |
p. 117-125
9 p.
|
artikel
|
| 10 |
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study
|
Grebely, Jason
|
|
2017
|
47 |
C |
p. 177-186
10 p.
|
artikel
|
| 11 |
Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy
|
Grebely, Jason
|
|
2017
|
47 |
C |
p. 26-33
8 p.
|
artikel
|
| 12 |
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia
|
Iversen, Jenny
|
|
2017
|
47 |
C |
p. 77-85
9 p.
|
artikel
|
| 13 |
Evaluation of a hepatitis C education intervention with clients enrolled in methadone maintenance and needle/syringe programs in Malaysia
|
Mukherjee, Trena I.
|
|
2017
|
47 |
C |
p. 144-152
9 p.
|
artikel
|
| 14 |
Healthcare contact and treatment uptake following hepatitis C virus screening and counseling among rural Appalachian people who use drugs
|
Stephens, Dustin B.
|
|
2017
|
47 |
C |
p. 86-94
9 p.
|
artikel
|
| 15 |
Hepatitis C testing in general practice settings: A cross-sectional study of people who inject drugs in Australia
|
Butler, Kerryn
|
|
2017
|
47 |
C |
p. 102-106
5 p.
|
artikel
|
| 16 |
High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic
|
Norton, Brianna L.
|
|
2017
|
47 |
C |
p. 196-201
6 p.
|
artikel
|
| 17 |
High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention
|
Puzhko, Svetlana
|
|
2017
|
47 |
C |
p. 61-68
8 p.
|
artikel
|
| 18 |
HIV and hepatitis C treatment uptake among people who use drugs participating in the Amsterdam Cohort Studies, 1985–2015
|
van Santen, Daniëla K.
|
|
2017
|
47 |
C |
p. 95-101
7 p.
|
artikel
|
| 19 |
‘I didn’t want to let it go too far.’ The decisions and experiences of people who inject drugs who received a liver disease assessment as part of a liver health promotion campaign: The LiveRLife study
|
Marshall, Alison D.
|
|
2017
|
47 |
C |
p. 153-160
8 p.
|
artikel
|
| 20 |
Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes
|
Mazhnaya, Alyona
|
|
2017
|
47 |
C |
p. 187-195
9 p.
|
artikel
|
| 21 |
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs: Findings from the Queensland Injectors’ Health Network
|
Morris, Leith
|
|
2017
|
47 |
C |
p. 216-220
5 p.
|
artikel
|
| 22 |
Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?
|
Panagiotoglou, Dimitra
|
|
2017
|
47 |
C |
p. 169-176
8 p.
|
artikel
|
| 23 |
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review
|
Bajis, Sahar
|
|
2017
|
47 |
C |
p. 34-46
13 p.
|
artikel
|
| 24 |
Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals
|
Mah, Allison
|
|
2017
|
47 |
C |
p. 137-143
7 p.
|
artikel
|
| 25 |
Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment ‘benefit’
|
Harris, Magdalena
|
|
2017
|
47 |
C |
p. 161-168
8 p.
|
artikel
|
| 26 |
Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascade
|
Scott, Nick
|
|
2017
|
47 |
C |
p. 107-116
10 p.
|
artikel
|
| 27 |
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs
|
Grebely, Jason
|
|
2017
|
47 |
C |
p. 51-60
10 p.
|
artikel
|
| 28 |
Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses
|
Lazarus, J.V.
|
|
2017
|
47 |
C |
p. 47-50
4 p.
|
artikel
|
| 29 |
Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection
|
Artenie, Andreea Adelina
|
|
2017
|
47 |
C |
p. 239-243
5 p.
|
artikel
|
| 30 |
Tensions in relation: How peer support is experienced and received in a hepatitis C treatment intervention
|
Bonnington, Oliver
|
|
2017
|
47 |
C |
p. 221-229
9 p.
|
artikel
|
| 31 |
Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996–2015
|
Graham, Simon
|
|
2017
|
47 |
C |
p. 69-76
8 p.
|
artikel
|
| 32 |
Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada
|
Mason, Kate
|
|
2017
|
47 |
C |
p. 202-208
7 p.
|
artikel
|
Tijdschrift beschrijving